Pharma-Bio Serv (PBSV) FCF Margin Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 138.00 |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 148.00 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 1,379.00 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 3,267.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 4,315.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -473.00 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 964.00 |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -3,758.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -3,758.00 |
| Oct 31, 2025 | 765.00 |
| Jul 31, 2025 | -1,117.00 |
| Apr 30, 2025 | -358.00 |
| Jan 31, 2025 | -1,085.00 |
| Oct 31, 2024 | -2,054.00 |
| Jul 31, 2024 | -3,666.00 |
| Apr 30, 2024 | -592.00 |
| Jan 31, 2024 | 1,742.00 |
| Oct 31, 2023 | 205.00 |
| Jul 31, 2023 | 164.00 |
| Apr 30, 2023 | 2,255.00 |
| Jan 31, 2023 | -1,212.00 |
| Oct 31, 2022 | 1,673.00 |
| Jul 31, 2022 | 3,594.00 |
| Apr 30, 2022 | 760.00 |
| Jan 31, 2022 | -170.00 |
| Oct 31, 2021 | 1,025.00 |
| Jul 31, 2021 | -2,753.00 |
| Apr 30, 2021 | -2,761.00 |
| Jan 31, 2021 | -2,360.00 |
| Oct 31, 2020 | -3,693.00 |
| Jul 31, 2020 | 3,230.00 |
| Apr 30, 2020 | -376.00 |
| Jan 31, 2020 | 3,495.00 |
| Oct 31, 2019 | -580.00 |
| Jul 31, 2019 | -418.00 |
| Apr 30, 2019 | -1,516.00 |
| Jan 31, 2019 | 214.00 |
| Oct 31, 2018 | -893.00 |
| Jul 31, 2018 | 4,257.00 |
| Apr 30, 2016 | -1,970.00 |
| Jan 31, 2016 | -1,170.00 |
| Oct 31, 2015 | -239.00 |
| Jul 31, 2015 | -2,033.00 |